MedPath

AMPHETAMINE SULFATE

Amphetamine Sulfate Tablets, USP, CII

Approved
Approval ID

89c5b52f-3c2a-41d5-8624-9ee51c512c72

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 26, 2023

Manufacturers
FDA

Solco Healthcare US, LLC

DUNS: 828343017

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

amphetamine sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43547-457
Application NumberANDA211861
Product Classification
M
Marketing Category
C73584
G
Generic Name
amphetamine sulfate
Product Specifications
Route of AdministrationORAL
Effective DateDecember 17, 2021
FDA Product Classification

INGREDIENTS (5)

AMPHETAMINE SULFATEActive
Quantity: 5 mg in 1 1
Code: 6DPV8NK46S
Classification: ACTIB
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

amphetamine sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code43547-458
Application NumberANDA211861
Product Classification
M
Marketing Category
C73584
G
Generic Name
amphetamine sulfate
Product Specifications
Route of AdministrationORAL
Effective DateDecember 17, 2021
FDA Product Classification

INGREDIENTS (5)

AMPHETAMINE SULFATEActive
Quantity: 10 mg in 1 1
Code: 6DPV8NK46S
Classification: ACTIB
CROSPOVIDONE (120 .MU.M)Inactive
Code: 68401960MK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT

Drug Labeling Information

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 9/26/2023

HOW SUPPLIED

Amphetamine sulfate tablets, USP, are supplied as follows:

**5 mg:**White, round, convex tablet, uppers scored and debossed "5" on the left side, lowers debossed "S" in bottles of 100 tablets with child-resistant closure, NDC 43547-457-10.

**10 mg:**White, round, convex tablet, uppers are double crossed scored and debossed "1" on the lower left corner and "0" on the lower right corner, lowers debossed "S" in bottles of 100 tablets with child-resistant closure, NDC 43547-458-10.

Store at 20° to 25°C (68° to 77°F); excursions permitted between 15oC and 30oC (59oF and 86oF). [see USP Controlled Room Temperature.] Dispense in a well- closed container, as defined in the USP.

Dispense with Medication Guide available at:

www.solcohealthcare.com/medguide/amphetamine- tablets.pdf

Manufactured by:

Prinston Laboratories

Charlotte, NC 28206, USA

Distributed by:

Solco Healthcare US, LLC

Somerset, NJ 08873, USA

Revised: 09/2023

9040380-06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMPHETAMINE SULFATE - FDA Drug Approval Details